Investor Relations
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Latest Financial Results
FY 2018
Fiscal Year Ended Dec 31, 2018
Stock Information
Company Overview
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Investor Contact Information
Company
Kane Biotech Inc.
162-196 Innovation Drive
Winnipeg, Manitoba R3T 2N2
Canada
T: 204.477.7592
ir@kanebiotech.com
Investor Relations
Edison Advisors
Joe Green
Senior Vice President, Investor Relations
1185 Avenue of the Americas
3rd Floor
New York, NY 10036
T: 646-653-7030
M: 917-575-7089
jgreen@edisongroup.com
Transfer Agent
Canadian Stock Transfer Company Inc.
600, 333 – 7th Avenue S.W.
Calgary, Alberta T2P 2Z1